Identification of p53 mutations in archival prostate tumors: Sensitivity of an optimized single-strand conformational polymorphism (SSCP) assay

Diagnostic Molecular Pathology

Volumn 5, Issue 4, 1996, Pages 271-278

  Shi, Xu Bao ^a   Bodner, Sara M ^a,b   DeVere White, Ralph W ^a   Gumerlock, Paul H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Archival tissue; p53; PCR; Prostate cancer; SSCP

Indexed keywords

CELL DNA;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; HUMAN; HUMAN CELL; MALE; MUTATION RATE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

DNA MUTATIONAL ANALYSIS; DNA REPAIR ENZYMES; DNA, NEOPLASM; EXODEOXYRIBONUCLEASES; GENES, P53; HUMANS; MALE; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029856286     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199612000-00008     Document Type: Article

References (38)

1. Bodner SM, Minna JD, Jensen SM, et al. Expression of mutant p53 protein in lung cancer correlates with the class of p53 gene mutation. Oncogene 1992;7:743-9.
2. Bookstein R, Allred DC. Recessive oncogenes. Cancer 1993;71:1179-86.
3. Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F, Allred DC. p53 is mutated in a subset of advanced-stage prostate cancers. Cancer Res 1993;53:3369-73.
4. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics. CA Cancer J Clin 1994;44:7-26.
5. Burmer GC, Loeb LA. Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma. Proc Natl Acad Sci USA 1989;86:2403-7.
6. Carroll AG, Voeller HJ, Sugars L, Gelmann EP. p53 oncogene mutations in three human prostate cancer cell lines. Prostate 1993;23:123-34.
7. Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993;341:1251-54.
8. Chi SG, DeVere White RW, Meyers FJ, Siders DB, Lee F, Gumerlock PH. p53 in prostate cancer: frequent expressed transition mutations. J Natl Cancer Inst 1994;86:926-33.
9. Dinjens WNM, Van Der Weiden MM, Schroeder FH, Bosman FT, Trapman J. Frequency and characterization of 53 mutations in primary and metastatic human prostate cancer. Int J Cancer 1994;56:630-3.
10. Effert PJ, McCoy RH, Walther PJ, Liu ET. p53 gene alternation in human prostate carcinoma. J Urol 1993;150:257-61.
11. Fearon ER, Feinberg AP, Hamilton SH, Vogelstein B. Loss of genes on the short arm of chromosome 11 in bladder cancer. Nature 1985;318:377-80.
12. Glavac D, Dean M. Optimization of the single-strand conformation polymorphism (SSCP) technique for detection of point mutation. Hum Mutat 1993;2:404-14.
13. Hall MC, Zagars GK, Navone NM, et al. Frequency and characterization of p53 mutation in clinically localized prostate cancer. Urology 1995;45:470-5.
14. Hayashi K, Yandell DW. How sensitive is PCR-SSCP? Hum Mutat 1993;2:338-46.
15. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.
16. Isaacs WB, Carter BS, Ewing CM. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res 1991;51:4716-20.
17. Kusser WC, Levin DB, Glickman BW. Sensitive two-stage PCR of p53 genomic DNA exons 5-9. PCR Methods Appl 1993;2:250-2.
18. Leren TP, Solberg K, Rodningen OK, Ose L, Tonstad S, Berg K. Evaluation of running conditions for SSCP analysis: application of SSCP for detection of point mutations in the LDL receptor gene. PCR Methods Appl 1993;3:159-62.
19. Michaud J, Brody LC, Steel G, Fontaine G, Martin LS, Valle D, Mitchell G. Strands-separating conformational polymorphism analysis: efficacy of detection of point mutations in the human ornithine δ-aminotransferase gene. Genomics 1992;13:389-394.
20. Mies C. Molecular pathology of paraffin-embedded tissue: current clinical applications. Diagn Mol Pathol 1992;1:206-11.
21. Mitsudomi T, Steinberg SM, Nau MM, et al. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 1992;7:171-80.
22. Navone NM, Troncoso P, Pisters LL, et al. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 1993;85:1657-69.
23. Oren M. p53: the ultimate tumor suppressor gene? FASEB J 1992;6:3169-76.
24. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphism of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989;86:2766-70.
25. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5: 874-9.
26. Prives C, Manfredi JJ. The p53 tumor suppressor protein: meeting review. Genes Dev 1993;7:529-34.
27. Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res 1993;53:3092-7.
28. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning, a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, 1989;9:14-23.
29. Schubert EL, Bischoff FZ, Whitaker LL, Pleasants LM, Hansen MF. A method to isolate DNA from small archival tissue samples for p53 gene analysis. Hum Mutat 1993;2: 123-26.
30. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM. The sensitivity of single-strand conformation polymor-phism analysis for the detection of single base substitutions. Genomics 1993;16:325-32.
31. Shi XB, Gumerlock PH, Wellman AA, et al. Rapid PCR construction of a gene containing Lym-1 antibody variable regions. PCR Methods Appl 1993;3:46-53.
32. Smith TA, Whelan J, Parry PJ. Detection of single-base mutations in a mixed population of cells: a comparison of SSCP and direct sequencing. Genet Anal Tech Appl 1992;9:143-5.
33. Suzuki Y, Sekiya T, Hayashi K. Allele-specific polymerase chain reaction: a method for amplification and sequence determination of a single component among a mixture of sequence variants. Anal Biochem 1991;192:82-4.
34. Van Veldhuizen PJ, Sadasivan R, Garcia F, Austenfeld MS, Stephens RL. Mutant p53 expression in prostate carcinoma. Prostate 1993;22:23-30.
35. Voeller HJ, Sugars LY, Pretlow T, Gelmann EP. p53 oncogene mutations in human prostate cancer specimens. J Urol 1994;151:492-5.
36. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
37. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992;70:523-6.
38. Wu JK, Ye Z, Darras BT. Sensitivity of single-strand conformation polymorphism (SSCP) analysis in detecting p53 point mutations in tumors with mixed cell populations. Am J Hum Genet 1993;52:1273-5.